Article
Providing Appropriate Risk Information on Genome Editing for Patients.
Trends in biotechnology - 1 Feb 2016
Araki Motoko, Ishii Tetsuya
Abstract excerpt
Genome editing, represented by CRISPR/Cas9, facilitates somatic and germline gene modifications in many species, including humans. However, one of key issues, off-target mutation deserves special consideration prior to clinical applications. We herein discuss the importance of risk information on genome editing for obtaining legitimate patient consent and social acceptance.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
